Cue Biopharma (CUE) Stock Price, Quote, News & History

Cue Biopharma Inc (CUE) Stock Price, Quote, News & History

CUENASDAQ

Trade with Public

$0.4723

-0.0296-5.90%

At close: Apr 13, 5:00 PM EST

$0.3805

-0.0918-19.44%

After Hours: 7:59 PM EST

Key Statistics

Open

$0.44

$0.47

Volume / Avg.

13.41M / 7.15M

Day Range

$0.40 - $0.50

52 Wk Range

0.17 - 1.03

Market Cap

$37.16M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

Recent Cue Biopharma Inc News

Cue Biopharma Receives $7.5M Milestone Payment From Boehringer Ingelheim

Cue Biopharma stock jumps after $7.5 million milestone from Boehringer Ingelheim, with additional milestone potential and pipeline progress.

Vandana Singh

What's Going On With Cue Biopharma Shares Tuesday?

Cue reported 2024 fiscal-year earnings on Monday after the market closed.

Dylan Berman

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-21.69M

Investing Cash Flow (TTM)

75.00K

Financing Cash Flow (TTM)

26.29M

Free Cash Flow (TTM)

-21.86M

Capital Expenditure (TTM)

-177.00K

Net Change in Cash (TTM)

4.68M

Valuation Metrics

Enterprise Value

$26.08M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

1.73

PB Ratio (TTM)

1.85

Earnings Yield % (TTM)

-55.79%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.27

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$4.50M

Total Cash

$27.14M

Debt to Equity

0.16

Issuance of Debt (TTM)

-$4.50M

Repayment of Debt (TTM)

-$4.50M

Key Statistics

Open

$0.44

$0.47

Volume / Avg.

13.41M / 7.15M

Day Range

$0.40 - $0.50

52 Wk Range

0.17 - 1.03

Market Cap

$37.16M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cue Biopharma (CUE) stock?

You can purchase shares of Cue Biopharma (NASDAQ:CUE) through any online brokerage.

View our list of the best stock brokerages

Who are Cue Biopharma (CUE) competitors?

There are no as such competitors for Cue Biopharma.

What is the forecast, or price target, for Cue Biopharma (CUE) stock?

There is no analysis for Cue Biopharma to provide a consensus price target.

What is the current price for Cue Biopharma (CUE)?

The stock price for Cue Biopharma (NASDAQ: CUE) is $0.3805 last updated April 13, 2026 at 7:59 PM EDT.

Does Cue Biopharma (CUE) pay a dividend?

There are no upcoming dividends for Cue Biopharma.

When is Cue Biopharma (NASDAQ:CUE) reporting earnings?

Cue Biopharma does not have any upcoming earnings scheduled.

Is Cue Biopharma (CUE) going to split?

There is no upcoming split for Cue Biopharma.

What sector and industry does Cue Biopharma (CUE) operate in?

Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Key Statistics

Open

$0.44

$0.47

Volume / Avg.

13.41M / 7.15M

Day Range

$0.40 - $0.50

52 Wk Range

0.17 - 1.03

Market Cap

$37.16M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

Recent Cue Biopharma Inc News

Cue Biopharma Receives $7.5M Milestone Payment From Boehringer Ingelheim

Cue Biopharma stock jumps after $7.5 million milestone from Boehringer Ingelheim, with additional milestone potential and pipeline progress.

Vandana Singh

What's Going On With Cue Biopharma Shares Tuesday?

Cue reported 2024 fiscal-year earnings on Monday after the market closed.

Dylan Berman

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Avi Kapoor